Prospectus
Released
Released
Announcement PDF
Prospectus
Atomos Limited
ACN 139 730 500
Entitlement Offer
1 for 1 non-renounceable pro rata entitlement offer of Atomos Limited (Company or AMS)
ordinary shares (Entitlement Offer Shares) at an offer price of A$0.02 per Entitlement Offer
Share to raise up to A$8 million (before costs), with 1 free quoted Option (exercisable at A$0.03
on or before 30 November 2025) for every 2 Entitlement Offer Shares applied for and issued
(Entitlement Offer Options) (Entitlement Offer).
The Entitlement Offer is fully underwritten by Henslow Pty Ltd ACN 605 393 137 AFSL 483168
(Lead Manager and Underwriter), and is fully sub-underwritten by the Company’s substantial
shareholder Domazet FT 3 Pty Ltd as trustee for The Domazet Family Trust A/C No 3 (Doma).
Placement Offer
A separate offer of 200,000,000 options to three of the Company’s directors (being Jeromy
Young, Peter Barber and Paul Greenberg (Participating Directors) or their nominees) and
Eligible Institutional Investors who participate in the Placement announced on 12 April 2024
(Placement), representing 1 free quoted Option for every 2 Placement Shares issued under the
Placement (Placement Options) (Placement Offer). The Placement Offer is conditional upon the
Company obtaining Shareholder approval to the issue of the Placement Shares and the
Placement Options at the Company’s extraordinary general meeting (EGM) scheduled to be held
on or about 16 May 2024, for which a notice of meeting is expected to be dispatched on or about
16 April 2024.
Broker Offer
An offer of 50,000,000 quoted Options (Broker Options) to Henslow Pty Ltd (Lead Manager), as
part of the consideration for the services provided by the Lead Manager to the Company in
relation to the capital raising (Broker Offer).
Executive Director Offer
A separate offer of 100,000,000 quoted Options (Executive Director Options) to the Company’s
executive directors (being Jeromy Young and Peter Barber (Executive Directors)) or their
nominees (Executive Director Offer). The Executive Director Offer is conditional upon the
Company obtaining Shareholder approval to the issue of the Executive Director Options at the
EGM.
Not for distribution or release in the United States.
page 1
3469-3746-8204, v. 1
IMPORTANT NOTICE
This Prospectus is a transaction specific prospectus issued in accordance with section 713 of the
Corporations Act 2001 (Cth). Accordingly, this Prospectus does not of itself contain the same
level of disclosure as an initial public offering prospectus. This is an important document which is
accompanied by a personalised entitlement and acceptance form and both should be read in their
entirety. Please call your stockbroker, accountant, financial adviser, taxation adviser or other
independent professional adviser or the share registry if you have any questions.
The Entitlement Offer, Placement Offer and Executive Director Offer close at 5:00PM
(AEST) on Monday 13 May 2024 (unless extended).
The Broker Offer closes at 5:00PM (AEST) on Monday 20 May 2024 (unless extended).
Valid applications in respect of the relevant Offer must be received before these times.
page 2
3469-3746-8204, v. 1
Important notice
Not for distribution or release in the United States
This Prospectus is dated 12 April 2024 and was lodged with
ASIC and the ASX on that date. Neither ASIC or the ASX or
their respective officers take any responsibility for the
contents of this Prospectus or the merits of the investment
to which this Prospectus relates.
No securities will be issued on the basis of this Prospectus
later than 13 months after the date of this Prospectus.
The Company will apply to ASX for official quotation of the
Entitlement Offer Shares, Entitlement Offer Options,
Placement Options, Broker Options and Executive Director
Options offered pursuant to this Prospectus.
Securities issued pursuant to this Prospectus will be issued
on the terms and conditions set out in this Prospectus.
This Prospectus is a transaction specific prospectus for an
offer of continuously quoted securities and options to
acquire continuously quoted securities (as defined in the
Corporations Act) and has been prepared in accordance
with section 713 of the Corporations Act. This Prospectus is
intended to be read in conjunction with the publicly available
information in relation to the Company which has been
notified to the ASX. It does not contain the same level of
disclosure as an initial public offering prospectus. In
preparing this Prospectus, regard has been had to the fact
that the Company is a disclosing entity for the purposes of
the Corporations Act and that certain matters may
reasonably be expected to be known to investors and
professional advisors whom investors may consult.
Investors should therefore have regard to all other
information disclosed to ASX in respect of the Company
before deciding whether to accept the applicable offer.
Manager Party expressly disclaims all duties and liabilities
(including for fault, negligence and negligent misstatement)
for any expenses, losses, damages or costs incurred by
you as a result of your participation in the Offer and this
Prospectus being inaccurate or incomplete in any way for
any reason. None of the Lead Manager Parties make any
recommendations as to whether you or your related parties
should participate in the Offer, nor do they make any
representations or warranties regarding the Prospectus or
the Offer, and you represent, warrant and agree that you
have not relied on any statements made by the Lead
Manager or any of the Lead Manager Parties in relation to
the Offer generally. You should rely only on the information
in this Prospectus.
Note to Applicants – Prospectus is not Financial or
Investment Advice
The information contained in this Prospectus is not
investment advice or financial product advice, and has been
prepared without taking into account your investment
objectives, financial situation or particular needs. It is
important that you read this Prospectus carefully and in full
before deciding whether to participate in the Offer and to
apply for applicable Shares and/or Options. In considering
an investment in the Company, you should consider the
risks that could affect the financial performance or position
of the Company as set out in Section 5 of this Prospectus.
You should carefully consider these risks in the light of your
investment objectives, financial situation and particular
needs (including financial and taxation issues) and seek
professional advice from your accountant, financial adviser,
stockbroker, lawyer or other professional adviser before
deciding whether to invest. The Shares and Options the
subject of this Prospectus should be considered highly
speculative. There may also be risks in addition to these that
should be considered in light of your personal
circumstances.
Obtaining a Prospectus
Investors should read this Prospectus in its entirety and
seek professional advice where necessary.
No Representation other than in this Prospectus
No person is authorised to give information or make any
representation in connection with this Prospectus that is
not otherwise contained within this Prospectus. Any
information or representation not so contained may not be
relied on as having been authorised by the Company, the
Lead Manager or any of their respective bodies corporate
and affiliates, nor any of their respective directors, officers,
partners, employees, representatives, contractors,
consultants, agents or advisers in connection with this
Prospectus.
Except as required by law, and only to the extent so
required, neither the Company nor any other person
(including any person named in this Prospectus) warrants
or guarantees the future performance of the Company or
any return on any investment made pursuant to this
Prospectus.
Neither the Lead Manager nor their related bodies
corporates or affiliates, nor any of their respective
directors, officers, partners, employees, representatives,
contractors, consultants, agents or advisers (together, the
Lead Manager Parties) has authorised, permitted or
caused the issue or lodgement, submission, despatch or
provision of this Prospectus and there is no statement in
this Prospectus which is based on any statement made by
the Lead Manager or by any of the Lead Manager Parties.
To the maximum extent permitted by law, each Lead
Eligible Shareholders who are entitled to participate in the
Entitlement Offer will receive a copy of this Prospectus
together with an accompanying personalised Entitlement
and Acceptance Form.
Eligible Shareholders in Australia, New Zealand and the
United Kingdom can also obtain a copy of this Prospectus
(free of charge) during the Entitlement Offer period from the
Company's website at www.atomos.com or by calling the
Share Registry on 1300 737 760 (from within Australia) or
+61 2 9290 9600 (from outside of Australia) from 8.30am to
5.30pm (Sydney time), Monday to Friday during the
Entitlement Offer period. Eligible Shareholders who access
the electronic version of this Prospectus on the Company's
website should ensure they download and read the entire
Prospectus. The electronic version of the Prospectus on the
Company's website will not include a personalised
Entitlement and Acceptance Form.
A copy of this Prospectus and an Application Form will be
sent by the Company to each Participating Director, Eligible
Institutional Investor, and the Lead Manager.
Shareholders in other jurisdictions (including the United
States), or who are, or are acting for the account or benefit
of, a person in the United States are not entitled to access
the electronic version of this Prospectus.
page 3
3469-3746-8204, v. 1
Past performance
No cooling-off period
Past performance and pro forma historical financial
information included in this Prospectus is given for
illustrative purposes only and should not be relied upon as
(and is not) an indication of the Company’s views on its
future financial performance or condition. Investors should
note that past performance, including past share price
performance, of the Company cannot be relied upon as an
indicator of (and provides no guidance as to) the Company’s
future performance including future Share price
performance. The historical information included in this
Prospectus is, or is based on, information that has
previously been released to the market.
No cooling off rights apply to applications submitted under
the Prospectus.
Investors should also be aware that certain financial data
included in this Prospectus may be ‘non-IFRS financial
information’ under Regulatory Guide 230 Disclosing nonIFRS financial information published by ASIC. The
Company believes this non-IFRS financial information
provides useful information to users in measuring the
financial performance and condition of the Company. The
non-IFRS financial information does not have a
standardised meaning prescribed by Australian Accounting
Standards and, therefore, may not be comparable to
similarly titled measures presented by other entities, nor
should they be construed as an alternative to other financial
measures determined in accordance with Australian
Accounting Standards. Investors are cautioned, therefore,
not to place undue reliance on any non-IFRS financial
information and ratios (if any) included in this Prospectus.
Forward looking statements
This Prospectus contains forward looking statements
which are identified by words such as ‘may’, ‘could’,
‘believes’, ‘estimates’, ‘expects’, ‘intends’ and other similar
words that involve risks and uncertainties. Any forwardlooking statements are subject to various risk factors that
could cause the Company’s actual results to differ
materially from the results expressed or anticipated in
these statements. Accordingly, such forward-looking
statements are provided as a general guide only and are
not guarantees of future performance. Forward-looking
statements involve known and unknown risks,
uncertainties, assumptions and other important factors,
many of which are beyond the control of the Company, the
Directors and management, and may cause the
Company’s actual results, performance or achievements to
materially differ from any future results, performance or
achievements expressed or implied from forward-looking
statements. The Company cannot and does not give any
assurance that the results, performance or achievements
expressed or implied by the forward-looking statements
contained in this Prospectus will actually occur and
prospective investors are cautioned against placing undue
reliance on these forward-looking statements. Neither the
Company, the Lead Manager, any of their respective
bodies corporate and affiliates, nor any of their respective
directors, officers, partners, employees, representatives,
contractors, consultants, agents or advisers give any
warranty, representation, assurance or guarantee that the
occurrence of the events expressed or implied from any
forward-looking statements in this Prospectus will actually
occur. Forward-looking statements should be read in
conjunction with, and are qualified by reference to, the risk
factors as set out in the Investor Presentation, as well as
the other information in this Prospectus.
The Company has no intention to update or revise forward
looking statements, regardless of whether new information,
future events or any other factors affect the information
contained in this Prospectus, except where required by law.
Company website
Any references to documents included on the Company’s
website at www.atomos.com are for convenience only, and
none of the documents or other information available on
the Company’s website are incorporated herein by
reference.
Defined terms and time
Capitalised terms and abbreviations used in this Prospectus
have the meanings given to them in the Glossary contained
in Section 7 of this Prospectus. Unless otherwise stated or
implied, references to times in this Prospectus are to AEST.
Disclaimer
Except as required by law, and only to the extent so
required, neither the Company nor any other person
warrants or guarantees the future performance of the
Company, or any return on any investment made pursuant
to this Prospectus.
As set out in Section 3.16 of this Prospectus, it is expected
that the Entitlement Offer Shares, Entitlement Offer
Options, Placement Options, Broker Options and Executive
Director Options will be quoted on ASX. The Company, the
Lead Manager and the Share Registry (in each case, as
defined below) disclaim all liability, whether in negligence or
otherwise, to persons who trade in any of those securities
before receiving their holding statements.
Selling restrictions
This Prospectus does not constitute an offer or invitation in
any place in which, or to any person to whom, it would not
be lawful to make such an offer or invitation. No action has
been taken to register or qualify the Shares or Options being
offered under the Offer, or to otherwise permit an offering of
the Shares or Options, in any jurisdiction outside Australia,
New Zealand, the United Kingdom and Singapore. The
distribution of this Prospectus outside Australia, New
Zealand, the United Kingdom and Singapore may be
restricted by law and persons who come into possession of
this Prospectus outside Australia, New Zealand, the United
Kingdom and Singapore should seek advice on and observe
any such restrictions. Any failure to comply with such
restrictions may constitute a violation of applicable
securities laws.
This Prospectus may not be released or distributed in the
United States or to any person acting for the account or
benefit of a person in the United States. This Prospectus
does not constitute an offer to sell, or a solicitation of offer
to buy, in the United States or in any other jurisdiction in
which such an offer would be unlawful.
In particular, the Shares and Options to be offered under
the Offer have not been, and will not be, registered under
the US Securities Act or the securities laws of any state of
the United States and may not be offered or sold in the
United States or to US Persons unless the Shares and/or
Options are registered under the US Securities Act, or
offered or sold in a transaction exempt from, or not subject
to, the registration requirements of the US Securities Act
and applicable US state securities laws.
page 4
3469-3746-8204, v. 1
For further detail please see the Foreign Selling Restrictions
set out in Section 6.7.
Privacy
By filling out an Application Form, you are providing
personal information to the Company through the
Company's share registry, Boardroom Pty Limited, which is
contracted by the Company to manage applications. The
Company, and the Share Registry on its behalf, may collect,
hold and use that personal information in order to process
your application, service your needs as an investor, provide
facilities and services that you request and carry out
appropriate administration. If you do not provide the
information requested in an Application Form, the Company
and the Share Registry may not be able to process or
accept your application.
information that the Company may wish to communicate to
its members) and compliance by the Company with legal
and regulatory requirements. An Applicant has a right to
gain access to the information that the Company and the
Share Registry hold about that person, subject to certain
exemptions under law. A fee may be charged for access.
Access requests must be made in writing or by telephone
call to the Company's registered office or the Share
Registry's office, details of which are disclosed in the
corporate directory set out on the last page of this
Prospectus.
Your personal information may also be provided to the
Company's members, agents and service providers on the
basis that they deal with such information in accordance
with the Company's privacy policy (which you may access
at www.atomos.com/privacy-policy/). The members, agents
and service providers of the Company may be located
outside Australia where your personal information may not
receive the same level of protection as that afforded under
Australian law. The types of agents and service providers
that may be provided with your personal information and the
circumstances in which your personal information may be
shared are:
▪
the Share Registry for ongoing administration of
the register of members;
▪
storage of subscriber data for the purpose of
webmail broadcasts;
▪
printers and other companies for the purpose of
preparation and distribution of statements and for
handling mail;
▪
market research companies for the purpose of
analysing the Shareholder base and for product
development and planning; and
▪
legal and accounting firms, auditors, contractors,
consultants and other advisers for the purpose of
administering, and advising on, the Company's
issued securities and for associated actions.
By submitting an Application Form, you agree that the
Company may use the information in the Application Form
for the purposes set out in this privacy disclosure statement
and may disclose it for those purposes to the Share
Registry, the Company’s related bodies corporate, agents,
contractors and third-party service providers, the ASX, the
ASIC and other regulatory authorities.
Collection, maintenance and disclosure of certain personal
information to the Company is governed by legislation
including the Privacy Act 1988 (Cth) (as amended from time
to time), the Corporations Act and certain rules such as the
ASX Settlement Operating Rules.
The information contained in the Company's register of
members must remain there even if that person ceases to
be a Shareholder. Information contained in the Company's
register of members is also used to facilitate dividend
payments and corporate communications (including the
Company's financial results, annual reports and other
page 5
3469-3746-8204, v. 1
Timetable of Offer
Event
Date
Announcement of Entitlement Offer, Placement, Executive Director
Offer, Broker Offer
Lodge Prospectus with ASIC and ASX and lodge Appendix 3B with
ASX
Friday 12 April 2024
Publication of Notice of EGM on ASX
Friday 12 April 2024
Notice of EGM dispatched to shareholders
Tuesday 16 April 2024
Record Date for Entitlement Offer
Thursday 18 April 2024
Prospectus and Application Forms dispatched
Tuesday 23 April 2024
Entitlement Offer opens
Placement Options Offer opens
Broker Offer opens
Executive Director Options Offer opens
Tuesday 23 April 2024
Entitlement Offer, Placement Options Offer, Executive Director
Options Offer close
Monday 13 May 2024
Announcement of results of Entitlement Offer
Wednesday 15 May 2024
EGM conducted
Thursday 16 May 2024
Settlement of Placement
Friday 17 May 2024
Settlement of Entitlement Offer (including any shortfall)
Friday 17 May 2024
Issue of Entitlement Offer Shares (and attaching Entitlement Offer
Options)
Issue of Placement Shares (and attaching Placement Options)
Issue of Executive Director Options
Monday 20 May 2024
Broker Offer closes
Monday 20 May 2024
Entitlement Offer Shares, Placement Shares and all Options (other
than Broker Options), commence trading on ASX*
Tuesday 21 May 2024
Issue of Broker Options
Tuesday 21 May 2024
Dispatch of holding statements in respect of Entitlement Offer
Shares and Placement Shares and all Options (other than Broker
Options)
Wednesday 22 May 2024
Broker Options commence trading on ASX*
Wednesday 22 May 2024
* Trading of all Shares and Options offered under this Prospectus is conditional upon the Company’s shares being re-instated to
trading. ASX has indicated that it sees no reason why the securities of the Company should not be reinstated to quotation,
subject to the satisfaction of certain conditions. Please see section 3.16 for more information.
Dates and times in this Prospectus are indicative only and subject to change. All times and dates refer to the time in Australian
Eastern Standard Time (AEST), Australia. The Company reserves the right, subject to the Corporations Act, ASX Listing Rules
and other applicable laws, to vary the dates of the Offer without prior notice, including extending the Entitlement Offer or
accepting late Applications, either generally or in particular cases, or to withdraw the Offer or part of the Offer without prior
notice. Applicants are encouraged to submit their personalised Application Forms as soon as possible. The commencement of
quotation of Entitlement Offer Shares, Entitlement Offer Options, Placement Options, Broker Options and Executive Director
Options is subject to confirmation from ASX.
Enquiries in relation to Entitlement Offer
page 6
3469-3746-8204, v. 1
Before making a decision about investing in the Entitlement Offer, you should seek advice from your
stockbroker, accountant, financial adviser, taxation adviser or other independent professional adviser
to determine whether it meets your objectives, financial situation and needs. If you have any questions
on how to:
1.
complete your personalised Entitlement and Acceptance Form; or
2.
take up the Entitlement Offer Shares (and Entitlement Offer Options) offered to you under
the Entitlement Offer, either in full or in part; or
3.
take up your full Entitlement and apply for Additional Entitlement Offer Shares (and
Entitlement Offer Options),
please call the Share Registry between 8.30am and 5.30pm (AEST) Monday to Friday during the
period from and including the date on which the Entitlement Offer opens until and including the date
on which it closes:
Within Australia: 1300 737 760
Outside Australia: +61 2 9290 9600
If you have misplaced your Entitlement and Acceptance Form and would like a replacement form,
please call the applicable number above. Alternatively, if you have the Shareholder Reference
Number or Holder Identification Number for your holding(s), you can download a replacement form
from the Share Registry's secure website at www.investorserve.com.au.
page 7
3469-3746-8204, v. 1
Contents
1.
Investment Overview ........................................................................................................... 15
1.1
1.2
1.3
2.
Company Overview and Financial Information ................................................................. 29
2.1
2.2
2.3
2.4
2.5
2.6
2.7
2.8
2.9
2.10
2.11
3.
Overview of the Entitlement Offer ........................................................................... 48
Purpose of Entitlement Offer and impact on capital structure ................................ 49
Eligibility to participate in Entitlement Offer ............................................................ 49
Oversubscription Applications ................................................................................ 49
Entitlements and acceptance ................................................................................. 50
Reconciliation ......................................................................................................... 51
Underwriting and role of Lead Manager ................................................................. 51
Nominees ................................................................................................................ 51
Removal of trading restrictions ............................................................................... 52
Risks ....................................................................................................................... 52
Options available to you ......................................................................................... 52
Ineligible Shareholders ........................................................................................... 54
How to accept your Entitlement .............................................................................. 54
Payment methods ................................................................................................... 55
Confirmation of your Application and managing your holding ................................ 56
ASX quotation and trading ...................................................................................... 56
No withdrawal or cooling-off rights ......................................................................... 58
Warranties made on acceptance of the Entitlement Offer ...................................... 59
Inconsistency .......................................................................................................... 61
Further information ................................................................................................. 61
Placement Offer ...................................................................................................... 61
Broker Offer ............................................................................................................ 62
Executive Director Offer.......................................................................................... 63
Purpose and Effect of the Offer .......................................................................................... 64
4.1
4.2
4.3
4.4
4.5
4.6
4.7
5.
Overview ................................................................................................................. 29
Products and Services Portfolio ............................................................................. 30
Revenue Model ....................................................................................................... 32
Proprietary Technology........................................................................................... 32
Strategic Technology Partners ............................................................................... 33
FY23 Financial Performance .................................................................................. 34
H1 FY24 Financial Performance ............................................................................ 36
Path Forward – Refocus and Refresh .................................................................... 37
Financial Outlook .................................................................................................... 42
Use of Proceeds ..................................................................................................... 43
Pro Forma Balance Sheet – Post Offer .................................................................. 43
Details of the Offer and How to Apply ............................................................................... 48
3.1
3.2
3.3
3.4
3.5
3.6
3.7
3.8
3.9
3.10
3.11
3.12
3.13
3.14
3.15
3.16
3.17
3.18
3.19
3.20
3.21
3.22
3.23
4.
Overview of Atomos Limited ................................................................................... 15
Overview of the Offer and How to Apply ................................................................ 16
Key risks ................................................................................................................. 23
Use of proceeds ...................................................................................................... 64
Effect on capital structure ....................................................................................... 64
Pre-commitments .................................................................................................... 65
Effect on control ...................................................................................................... 65
Underwriting ............................................................................................................ 67
Sub-underwriting arrangements by Doma .............................................................. 72
Mandate Letter ........................................................................................................ 72
Key risks ............................................................................................................................... 73
5.1
5.2
R
Share your feedback
Discover